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Despite its preventability, lead poisoning
remains a common pediatric problem (1-3).
Lead primarily affects three target organs in
children: brain, kidney, and blood-forming
organs (4). Lead is especially toxic for young
children (4-8). Immature organs are most
susceptible to damage at their time of most
rapid growth, accounting for the observa-
tion that the brain is most vulnerable in the
first 2 years oflife (8). The blood-brain bar-
rier takes 3 years to complete development;
therefore, lead ingested by toddlers enters
the central nervous system more readily
(3-7). Furthermore, absorption and
bioavailability of ingested lead is four times
greater in children than in adults--40% ver-
sus 10%. Risk oflead ingestion is increased
in young children by pica and normal hand-
to-mouth exploratory behavior (5-9). In
1990, the EPA estimated that 3 million of
the nation's children under 6 years of age
had blood lead levels >10 pig/dl, the level
statistically associated with subsequent lower
intellectual performance and other adverse
health effects (10-14). Not only can lead-
intoxicated children have impaired intelli-
gence but they also are frequently overactive,
aggressive, more distractible, disorganized,
and less able to follow directions (15-17).
Longitudinal studies ofyoung children with
high lead levels have shown lower class
standing in the final year of high school,
with increased absenteeism, lower vocabu-
lary scores, and impaired motor function
(8,18). The sources and pathways of lead
exposure are well enough known that seri-
ous preventive efforts intended to eradicate
childhood lead toxicity are now under way
(4-6,9,14,18).
Lead screening has been conducted
throughout Texas since 1973 as part ofthe
Early Periodic Screening, Diagnosis and
Treatment (EPSDT) program. The
national standard for acceptable blood lead
concentrations was originally set at <40
jxg/dl in 1973, and this standard was used
to test Texas Medicaid recipients (19). In
1976, the Texas Department of Health
laboratory changed its lead screening
methodology to erythrocyte protopor-
phyrin (EP) testing coupled with blood
lead analysis for detecting potential lead
problems (20). Only children under 6
years ofage were required to be tested; the
level considered normal in 1976 was an EP
level below 50 pg/di, with a corresponding
blood lead level below 30 pg/dl. In 1986,
the threshold for a normal blood lead level
was further lowered to 25 pg/dl, with a
corresponding EP level of35 flg/dl (21). In
October 1991, the Centers for Disease
Control and Prevention (CDC) set the
current level for acceptable blood lead con-
centration at <10 pg/dl, a level believed
not to be harmful to children (5). In
October 1992, the Texas Department of
Health Laboratories began using a graphite
furnace atomic absorption spectropho-
tometer (GFAAS) analytic method, which
allowed more accurate determination of
blood lead concentrations at these lower
levels (22).
The aim ofthis study was to determine
demographic risk factors for high lead lev-
els in Texas children tested during routine
Medicaid screening, and it focused on gen-
der, ethnicity, and age.
Design
The study population consisted of all the
Texas children covered by Medicaid screened
for blood lead for 6 months (1 January-30
June 1993). The specimens were collected by
well-child clinics in local health departments
and by office-based private physicians.
Samples were eithervenous or capillary speci-
mens, at the physician's discretion. Program
guidelines request that all follow-up speci-
mens be venous in order to reduce the possi-
bility ofskin lead contamination, which may
occur with poorly collected capillary speci-
mens. Venous specimens for verification of
initial high results were requested at 3-month
intervals following therapeutic intervention.
All specimens were analyzed by the Texas
Department of Health (TDH) laboratory in
Austin, Texas, using GFAAS methodology
(22. Submitters received laboratory reports
7-10 days afterspecimen collection.
Age ofsubjects was imputed as the differ-
ence between date of birth and 30 June
1993, the last date ofthe 6-month collection
period. The dates of specimen collection
were not included in the magnetic data file
made available for this study so exact ages of
subjects were notavailable for this study.
Analysis was performed using SPSS
(Statistical Package for Social Sciences;
SPSS Inc., Chicago, IL). Specific hypothesis
testing or parameter estimation was consid-
ered inappropriate for this exploratory
study. Only descriptive statistics were used:
frequency distributions, cross-tabulations,
and percentiles/quartiles.
Results
During the first 6 months of 1993, TDH
received 92,900 blood specimens for lead
testing from Texas children covered by
Medicaid who were at least 6 months ofage.
This total includes multiple blood specimens
for children receiving repeat tests during this
period. Capillary and venous specimens
could not be examined separately because
there was no coding ofspecimen type in the
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records reviewed. Of the 92,900 specimens
collected, 98.9% were adequate for valid
lead testing. Incomplete demographic data
information affected 7,624 (8.2%) of the
specimens withvalid lead determinations.
Ofthe 91,783 valid lead determinations
reviewed, 90.3% were not elevated, 6.1%
were in the 10-14 pg/dl range, 1.4% were in
the 15-19 /dl range, and only 0.9% were
.20 /dl (see Fig. 1). Figures 1 and 2 show
that elevated blood lead occurred mostly in
children of1-5 years ofage (13-72 months).
Children 25-36 months old had the highest
rate of elevated levels (14.3%), followed by
those 19-24 months old (13.0%) and37-48
monthsold (12.0%).
Of the specimens with ethnicity record-
ed, 53.3% were Hispanic, 20.8% were
white, and 20.0% were African American.
The remainder (5.9%) comprised diverse
ethnicities, each ofwhich was too small a
subgroup for meaningful statistical interpre-
tation. African Americans had the highest
prevalence rates in each age group (see Table
1). The highest prevalence rate was among
African American children in the 2-4 year-
old age group (17.3%); this was 3.5 times
higher than that of the lowest prevalence
group [whites over4yearsofage (4.9%)].
Males constituted 48.9% ofthe children
tested, and48.1% were females. Genderwas
not given in 3% of the specimens submit-
ted; these were excluded in the comparisons
involving gender. This estimated sex ratio of
1.02 suggests no overall effect ofgender on
the likelihood of receiving lead screening.
Males had a higher prevalence rate ofelevat-
ed blood lead at all ages. The age-specific
rate ratios resemble the sex ratios for elevat-
ed lead, with the overall sex ratio for all ages
being 1.15. This indicates a 15% greater
likelihood ofan elevated blood lead level in
males. In the youngest age group, 0-6
months, the sample size was too small, and
perhaps not representative enough, to enable
reliable interpretations. The remaining 12
older age groups suggest consistently
increased risk in boys. The prevalence rate
ratios ranged from 1.02 to 1.29 for boys in
age groups under 4 years and 1.14 to 2.13
for boys in the older age groups. The aver-
age combined prevalence rate ratio for all
young males under 48 months was 1.1 and
forall males over48 monthswas 1.4.
The highest blood lead concentration
was 70 tig/dl, which occurred in an African
American female in the 25-36 months age
group. The characteristics of this case are
those expected in terms ofage and ethnici-
ty, but this level was nottypical in afemale.
Discussion
This study was limited by the inability to
identify: 1) duplicate specimens for indi-
vidual children, 2) false positives or false
negatives, and 3) remote past exposure or a
lifetime peak exposure (this cross-sectional
study of single blood specimens reflects
predominantly recent exposure to lead).
Nonetheless, this study suggests three risk
factors for excessive blood lead in children:
ethnicity (African American), gender
(male), and age (13-72 months of age).
Results did not show variation in preva-
lence rates ofhigh blood lead by geograph-
ic location (not shown); the distribution of
lead values appeared similar in residents of
urban and rural counties ofTexas. Because
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Figure 1. Percent of abnormal blood specimens from Texas children covered by Medicaid by age and
lead concentration, Januarythrough June 1993. *Denotes the number of children in that category.
Table 1. Number of blood lead specimens and percent with elevated lead concentration (>10 pg/dl) by
age and ethnicitya
Age (year) White Hispanic African American Total
No. Elevated, % No. Elevated, % No. Elevated, % No. Elevated, %
<2 9,501 6.03 22,300 7.41 7,440 8.01 39,241 7.19
2-4 3,832 10.46 11,229 12.72 4,316 17.26 19,377 13.28
>4 5,545 4.87 15,031 7.08 6,471 9.32 2,704 7.16
Total 18,878 6.59 48,560 8.53 18,227 10.67 85,665 8.56
aExcluded were 6,233 specimens with missing data for age and/or ethnicity; 1,002 specimens were
excluded as being coded to ethnic groups otherthanwhite,African American, or Hispanic.
Figure 2. Percent of blood lead specimens from
Texas children covered by Medicaid by age group
and ethnicity, Januarythrough June 1993.
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the study population consisted of Texas
Medicaid recipients who are necessarily
near or below the federally defined poverty
level, these findings cannot be generalized
directly to the remainder of the childhood
population in Texas. The data do not pro-
vide information on the prevalence oflead
in children ofaffluent families.
Since the late 1970s, ongoing contami-
nation ofthe U.S. environment by lead has
been substantially reduced as major uses of
lead in house paint, gasoline, water distrib-
ution systems, and food cans have been
reduced or eliminated (5). Between 1976
and 1980, the second National Health and
Nutrition Examination Survey (NHANES
II) collected blood lead data from selected
populations and from convenience sam-
ples, confirming a continued decline in
blood lead levels (23-25). For the last half
of the 1970s, that survey found that
African Americans had a 12.2% prevalence
rate compared to 2.0% in whites for blood
lead levels over 30 pg/dl among children 6
months-5 years ofage in the income group
$6,000-15,000/year and living in large
urban areas (23-25). There were signifi-
cant but complex associations between
income, ethnicity, and lead concentration.
There was a stronger inverse relation
between income and lead levels in African
Americans than in whites. About one-sixth
(18.5%) of African American children
from low-income households (less than
$6,000/year) had blood lead concentra-
tions high enough to qualify for medical
follow-up (23-25).
Phase I of the NHANES III survey
took place from October 1988 through
October 1991 and showed a 78% decline
in the estimated geometric mean in blood
lead levels in the U.S. population (26-28).
This decrease was similar across all age
groups, leaving the cross-sectional age pat-
tern virtually unchanged (26-28). The
highest geometric mean was for children
1-2 years old (4.1 jig/dl) and the lowest
was for those 12-19 years old (1.6 jtg/dl).
The prevalence of blood lead levels .10
pg/dl among children aged 1-5 years
decreased substantially from 88.2% during
NHANES II to 8.9% during NHANES
III, Phase I. Prevalence of elevated blood
lead levels continued to vary by race/eth-
nicity, income, and residence (26-28).
Despite the decline in childhood lead expo-
sure, approximately 1.7 million children
aged 1-5 years still have blood lead con-
centrations at or above 10pg/dl (26-28).
Results of this study of Texas children
covered by Medicaid are consistent with
the NHANES II and Phase I of the
NIANES III results in identifying the role
ofethnicity and income. The demographic
pattern of elevated blood lead levels in
Texas children covered by Medicaid proba-
bly reflects the distribution of the two
major remaining environmental reservoirs
oflead contamination: deteriorated indoor
lead paint in older housing and urban soil
and dust contaminated by past emissions of
leaded gasoline and by exterior paint on
structures (1,26). While it is not possible to
arrive at valid incidence rates from the data
due to the limitations previously described,
the existence of clinically significant levels
of lead exposure in this study group is
undeniable. As many as 8% ofthe children
tested may have lead values in excess of 10
pg/dl and thus may be at risk for develop-
mental problems. These data indicate the
need for continued vigilance in order to
minimize exposure to environmental
sources of lead, especially in toddlers and
preschoolers. To assess the lead risk in
Texas children in greater detail, the data-
reporting system will need to identify
duplicate results and whether the specimen
is capillary or venous. Steps have been
taken to accommodate these needs through
recent data collection changes in the Texas
EPSDT program. This study has also con-
firmed the need for expanded consumer
education regarding the risks of increased
blood lead concentrations. The need for
expanded screening of young children is
supported by these data. A risk assessment
study in children not covered by Medicaid
would be desirable.
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